BP plc (BP) stock saw a modest uptick, ending the day at $28.96 which represents a slight increase of $0.11 or 0.38% from the prior close of $28.85. The stock opened at $28.82 and touched a low of $28 ...
BP-1002 is under clinical development by Bio-Path and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData, Phase I drugs for Cutaneous T-Cell Lymphoma have an 84% phase ...